Home » Topics » Conferences

Conferences
RSS

Integrin antagonist S-787 prevents ovariectomy-induced bone loss in rats

Oct. 5, 1999

ASBMR participants learn of efficacy, safety of risedronate in several large studies

Oct. 5, 1999

ICAAC news: anti-HIV-1 activity and enzyme/drug interactions of (+)-calanolide A

Oct. 4, 1999

Compound from Streptomyces inhibits bone resorption, induces apoptosis in osteoclasts in vitro

Oct. 4, 1999

Geranylgeranyltransferase inhibition as a mechanism for specifically inhibiting bone resorption

Oct. 4, 1999

Profile of new small-molecule CCR5 antagonist from Takeda detailed further at ICAAC

Oct. 4, 1999

Novel semisynthetic pleuromutilins with potential as topical antibacterial agents

Oct. 4, 1999

In vivo efficacy and CNS toxicity of T-3811ME described at major congress

Oct. 4, 1999

Lilly's PTH analogue LY-333334 featured at this week's ASBMR meeting

Oct. 4, 1999

Promising anti-HIV drug candidate strongly inhibits T-tropic and T/M-tropic infections in SCID mice

Oct. 4, 1999

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...